<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38585924</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2693-5015</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Research square</Title><ISOAbbreviation>Res Sq</ISOAbbreviation></Journal><ArticleTitle>Racial/Ethnic Differences in Long-COVID-Associated Symptoms among Pediatrics Population: Findings from Difference-in-differences Analyses in RECOVER Program.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">rs.3.rs-4151744</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21203/rs.3.rs-4151744/v1</ELocationID><Abstract><AbstractText>Racial/ethnic differences are associated with the potential symptoms and conditions of post-acute sequelae SARS-CoV-2 infection (PASC) in adults. These differences may exist among children and warrant further exploration. We conducted a retrospective cohort study for children and adolescents under the age of 21 from the thirteen institutions in the RECOVER Initiative. The cohort is 225,723 patients with SARS-CoV-2 infection or COVID-19 diagnosis and 677,448 patients without SARS-CoV-2 infection or COVID-19 diagnosis between March 2020 and October 2022. The study compared minor racial/ethnic groups to Non-Hispanic White (NHW) individuals, stratified by severity during the acute phase of COVID-19. Within the severe group, Asian American/Pacific Islanders (AAPI) had a higher prevalence of fever/chills and respiratory symptoms, Hispanic patients showed greater hair loss prevalence in severe COVID-19 cases, while Non-Hispanic Black (NHB) patients had fewer skin symptoms in comparison to NHW patients. Within the non-severe group, AAPI patients had increased POTS/dysautonomia and respiratory symptoms, and NHB patients showed more cognitive symptoms than NHW patients. In conclusion, racial/ethnic differences related to COVID-19 exist among specific PASC symptoms and conditions in pediatrics, and these differences are associated with the severity of illness during acute COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0835-0788</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dazheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bingyu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0001-5747-1899</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Jiayi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1213-6699</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yiwen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiajie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiyuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chisolm</LastName><ForeName>Deena</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Abigail Wexner Research Institute Nationwide Children's Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhaveri</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ann &amp; Robert H. Lurie Children's Hospital of Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenney</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>New York University Grossman School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothman</LastName><ForeName>Russel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Suchitra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine and Children's Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hornig</LastName><ForeName>Mady</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Columbia University Mailman School of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8520-6088</Identifier><AffiliationInfo><Affiliation>University of Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forrest</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R56 AG069880</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 TR003709</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG077820</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM013519</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012607</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI130460</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG074604</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG073435</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Sq</MedlineTA><NlmUniqueID>101768035</NlmUniqueID><ISSNLinking>2693-5015</ISSNLinking></MedlineJournalInfo><CoiStatement>Declarations DISCLOSURES COMPETING INTERESTS Dr. Jhaveri is a consultant for AstraZeneca, Seqirus, and Dynavax, and receives an editorial stipend from Elsevier and Pediatric Infectious Diseases Society and royalties from Up To Date/Wolters Kluwer. Dr. Rao reports prior grant support from GSK and Biofire and is a consultant for Sequiris. All other authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38585924</ArticleId><ArticleId IdType="pmc">PMC10996810</ArticleId><ArticleId IdType="doi">10.21203/rs.3.rs-4151744/v1</ArticleId><ArticleId IdType="pii">rs.3.rs-4151744</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329(22):1934&#x2013;1946. doi:10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus, 16 February 2023. Published online 2023.</Citation></Reference><Reference><Citation>Morello R, Mariani F, Mastrantoni L, et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. EClinicalMedicine. 2023;59. doi:10.1016/j.eclinm.2023.101961</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J, Havdal LB, Drevvatne M, et al. Prevalence and Characteristics Associated With Post&#x2013;COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults. JAMA Netw Open. 2023;6(3):e235763&#x2013;e235763. doi:10.1001/jamanetworkopen.2023.5763</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5763</ArticleId><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales AJ, Lopez-Echeverri MC, Perez-Raga MF, et al. The global challenges of the long COVID-19 in adults and children. Travel Med Infect Dis. Published online 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10247301</ArticleId><ArticleId IdType="pubmed">37295581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568&#x2013;e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417&#x2013;e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Lee GM, Razzaghi H, et al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176(10):1000&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Twohig H, Bajpai R, Corp N, et al. Long-term outcomes of COVID-19 infection in children and young people: a systematic review and meta-analysis. medRxiv. Published online 2023:2023&#x2013;2024.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo del Valle NC, et al. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistics, U.S. Census Bureau, Household Pulse Survey. Long COVID. Published
2022. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm</Citation></Reference><Reference><Citation>Khullar D, Zhang Y, Zang C, et al. Racial/ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-based cohort study from the RECOVER program. J Gen Intern Med. 2023;38(5):1127&#x2013;1136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9933823</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ME, Kelly PA. Conceptualizing and Categorizing Race and Ethnicity in Health Services Research. Health Serv Res. 2005;40(5p2):1658&#x2013;1675. doi:10.1111/j.1475-6773.2005.00449.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-6773.2005.00449.x</ArticleId><ArticleId IdType="pmc">PMC1361221</ArticleId><ArticleId IdType="pubmed">16179001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford CL, Harawa NT. A new conceptualization of ethnicity for social epidemiologic and health equity research. Soc Sci Med. 2010;71(2):251&#x2013;258. doi:10.1016/j.socscimed.2010.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2010.04.008</ArticleId><ArticleId IdType="pmc">PMC2908006</ArticleId><ArticleId IdType="pubmed">20488602</ArticleId></ArticleIdList></Reference><Reference><Citation>Saatci D, Ranger TA, Garriga C, et al. Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England. JAMA Pediatr. 2021;175(9):928&#x2013;938. doi:10.1001/jamapediatrics.2021.1685</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.1685</ArticleId><ArticleId IdType="pmc">PMC8218232</ArticleId><ArticleId IdType="pubmed">34152371</ArticleId></ArticleIdList></Reference><Reference><Citation>Swann O V HKATLPLFCJDTM et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370(m3249).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488201</ArticleId><ArticleId IdType="pubmed">32960186</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandi S, Nevid MZ, Mahdavinia M. African American children are at higher risk of COVID-19 infection. Pediatric Allergy and Immunology. 2020;31(7):861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283894</ArticleId><ArticleId IdType="pubmed">32469426</ArticleId></ArticleIdList></Reference><Reference><Citation>Swann O V, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. bmj. 2020;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488201</ArticleId><ArticleId IdType="pubmed">32960186</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kepler KL, Geevarughese A, et al. Race/ethnicity among children with COVID-19&#x2013;associated multisystem inflammatory syndrome. JAMA Netw Open. 2020;3(11):e2030280&#x2013;e2030280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7705594</ArticleId><ArticleId IdType="pubmed">33252688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisolm DJ, Webb R, Salamon K, et al. Associations between area-level health-related social factor indices and risk of acute COVID-19: An EHR-based cohort study from the RECOVER program. medRxiv. Published online 2022:2012&#x2013;2022.</Citation></Reference><Reference><Citation>Rao S, Lee GM, Razzaghi H, et al. Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program. medRxiv. Published online 2022.</Citation></Reference><Reference><Citation>Forrest CB, Burrows EK, Mejias A, et al. Severity of acute COVID-19 in children&lt; 18 years old March 2020 to December 2021. Pediatrics. 2022;149(4):e2021055765.</Citation><ArticleIdList><ArticleId IdType="pubmed">35322270</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S, Pearl J, Robins JM. Confounding and collapsibility in causal inference. Statistical science. 1999;14(1):29&#x2013;46.</Citation></Reference><Reference><Citation>Whitcomb BW, Naimi AI . Defining, quantifying, and interpreting &#x201c;noncollapsibility&#x201d; in epidemiologic studies of measures of &#x201c;effect.&#x201d; Am J Epidemiol. 2021;190(5):697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530151</ArticleId><ArticleId IdType="pubmed">33305812</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083&#x2013;3107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Khullar D, Zhang Y, Zang C, et al. Racial/ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-based cohort study from the RECOVER program. J Gen Intern Med. 2023;38(5):1127&#x2013;1136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9933823</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoah J, Stuart EA, Cosgrove SE, et al. Comparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections. Clin Infect Dis. 2020;71(9):e497. doi:10.1093/CID/CIAA169</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAA169</ArticleId><ArticleId IdType="pmc">PMC7713675</ArticleId><ArticleId IdType="pubmed">32069360</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisolm DJ, Webb R, Salamon K, et al. Associations between area-level health-related social factor indices and risk of acute COVID-19: An EHR-based cohort study from the RECOVER program. medRxiv. Published online 2022:2012&#x2013;2022.</Citation></Reference><Reference><Citation>Asch DA, Sheils NE, Islam MN, et al. Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic. JAMA Intern Med. 2021;181(4):471&#x2013;478. doi:10.1001/JAMAINTERNMED.2020.8193</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAINTERNMED.2020.8193</ArticleId><ArticleId IdType="pmc">PMC7756246</ArticleId><ArticleId IdType="pubmed">33351068</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir M, Cook N, Parras D, et al. Using Data Science and a Health Equity Lens to Identify Long-COVID Sequelae Among Medically Underserved Populations. J Health Care Poor Underserved. 2023;34(2):521&#x2013;534. doi:10.1353/HPU.2023.0047</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/HPU.2023.0047</ArticleId><ArticleId IdType="pubmed">37464515</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R, Cao M, Wu Y, et al. An Empirical Study for Impacts of Measurement Errors on EHR based Association Studies. AMIA Annual Symposium Proceedings. 2016;2016:1764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333313</ArticleId><ArticleId IdType="pubmed">28269935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Wang J, Chubak J, Hubbard RA. Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: empirical illustration using breast cancer recurrence. Pharmacoepidemiol Drug Saf. 2019;28(2):264&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6716793</ArticleId><ArticleId IdType="pubmed">30375122</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proceedings of the National Academy of Sciences. 2018;115(11):2571&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33(2):209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>